Immunocore PRAME Investor & Analyst Event at ESMO 2022

Paris, September 9, 2022

Following the presentation at ESMO, Immunocore will host an in-person and webcasted investor and analyst event at 6:30 PM CEST / 12:30 PM EDT on Friday, September 9th

Date & Time: Friday, September 9th

Registration begins at 6:15 PM CEST

Presentation with hors d’oeuvres to follow from 6:30 to 8:00 PM CEST

Location: Espace56, Montparnasse Tower

Address: 33 Av. du Maine, 75015, Paris, France

The webcast will be available on the 'Events' section of the Immunocore website

RSVP for Event / Log Back in Presenter Access

Additional menu options can be found in the menu bar on the left or at the top.

Immunocore [IMCR] $2,824 MM MCap
A pi­oneer­ing, com­mer­cial-stage T cell re­cep­tor biotech­nol­o­gy com­pany work­ing to de­vel­op and com­mer­cial­ize a new gen­er­a­tion of trans­for­ma­tive medicines to ad­dress un­met needs in can­cer, in­fec­tion and au­toim­mune dis­ease, with the first TCR ther­a­peu­tic to re­ceive reg­u­la­to­ry ap­pro­val. [more in­for­ma­tion]

Event Contact

William Windham
Solebury Strategic Communications